Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Anticoagulation

Davide Capodanno: Independent Investigators Lead the First Head to Head DOAC Comparison
Mar 29, 2026, 16:15 | Science
Davide Capodanno: Independent Investigators Lead the First Head to Head DOAC Comparison
Davide Capodanno, Full Professor of Cardiology at the University of Catania, shared a post on LinkedIn…
Pooja Choradia: Obesity and Pulmonary Embolism - The Hidden Prothrombotic State
Mar 28, 2026, 18:32 | Voices
Pooja Choradia: Obesity and Pulmonary Embolism - The Hidden Prothrombotic State
Pooja Choradia, Critical care associate at P.D. Hinduja Hospital Khar, shared a post on LinkedIn:…
Ifeanyichukwu Ifechidere: Breaking the INR Myth in Liver Disease
Mar 26, 2026, 17:00 | Voices
Ifeanyichukwu Ifechidere: Breaking the INR Myth in Liver Disease
Ifeanyichukwu Ifechidere, Specialist Biomedical Scientist at Sheffield Teaching Hospitals NHS Foundation Trust, shared a post…
Anna Oleksiak: Anticoagulation In Real Life Challenges And Patient Oriented Decisions
Mar 25, 2026, 14:38 | Voices
Anna Oleksiak: Anticoagulation In Real Life Challenges And Patient Oriented Decisions
Anna Oleksiak, Cardiologist at National Institute of Cardiology Stefan Cardinal Wyszyński – National Research Institute,…
Sebastian Szmit: Latest Insights into VTE Management in Cancer Patients
Mar 21, 2026, 15:46 | Voices
Sebastian Szmit: Latest Insights into VTE Management in Cancer Patients
Sebastian Szmit, Head of Department of Cardio-Oncology, Centrum Medycznego Kształcenia Podyplomowego, shared a post on LinkedIn about…
Eva Soler Espejo։ Atherogenic Index of Plasma and Residual Risk in Atrial Fibrillation
Mar 20, 2026, 16:23 | Science
Eva Soler Espejo։ Atherogenic Index of Plasma and Residual Risk in Atrial Fibrillation
Eva Soler Espejo, Consultant Hematologist at Virgen de la Arrixaca University Clinical Hospital, shared a…
Akinchan Bhardwaj: Differences in Bleeding Outcomes Among DOACs
Mar 19, 2026, 17:14 | Science
Akinchan Bhardwaj: Differences in Bleeding Outcomes Among DOACs
Akinchan Bhardwaj, Consultant Interventional Cardiologist at Kauvery Hospital, shared a post on LinkedIn about a recent…
Amir Kraitzer: Engineering Hemocompatible Surfaces to Overcome Thrombosis in Medical Devices
Mar 18, 2026, 16:15 | Voices
Amir Kraitzer: Engineering Hemocompatible Surfaces to Overcome Thrombosis in Medical Devices
Amir Kraitzer, Independent MedTech and Innovation Consultant, shared a post on LinkedIn: "Each year, millions…
Heghine Khachatryan: PFO, Cryptogenic Stroke, and Factor V Leiden - Closure or Lifelong Anticoagulation?
Mar 17, 2026, 14:58 | Voices
Heghine Khachatryan: PFO, Cryptogenic Stroke, and Factor V Leiden - Closure or Lifelong Anticoagulation?
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology…
Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib - The Clinical Tightrope
Mar 15, 2026, 14:09 | Voices
Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib - The Clinical Tightrope
Abdul Mannan, Consultant Hematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:…
Mandy Lauw: Can Reduced-Dose DOACs Be Applied to All Patients With VTE?
Mar 13, 2026, 10:00 | Voices
Mandy Lauw: Can Reduced-Dose DOACs Be Applied to All Patients With VTE?
Mandy Lauw, Internist-hematologist at Erasmus MC, shared a post on LinkedIn about a recent article…
Zeeshan Ahmed Khattak: Certification Pathways in Anticoagulation for Pharmacists
Mar 9, 2026, 15:24 | Voices
Zeeshan Ahmed Khattak: Certification Pathways in Anticoagulation for Pharmacists
Zeeshan Ahmed Khattak, Pharmacist (IP/Oncology) at Abu Dhabi Stem Cells Center, shared on LinkedIn: ''Certifications…
Samwel Mikaye։ Key Insights on Stroke Types, Diagnosis, and Management
Mar 4, 2026, 15:46 | Voices
Samwel Mikaye։ Key Insights on Stroke Types, Diagnosis, and Management
Samwel Mikaye, Medical Doctor at MSK, shared a post on LinkedIn: ''Stroke (Cerebrovascular Accident – CVA)…
Abdul Mannan: A Practical Guide to Anticoagulation Stewardship
Mar 4, 2026, 14:36 | Voices
Abdul Mannan: A Practical Guide to Anticoagulation Stewardship
Abdul Mannan, Consultant Hematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn: "Most…
Lim Wan Chieh: Choosing Which Risk to Prioritise in Frail Older Adults
Mar 4, 2026, 13:11 | Voices
Lim Wan Chieh: Choosing Which Risk to Prioritise in Frail Older Adults
Lim Wan Chieh, Geriatrician and Internal Medicine Specialist at Sunway Medical Centre Ipoh, shared a…
Cheng-Hock Toh։ The Unrecognised Central Role of Hematology in Healthcare Design
Mar 3, 2026, 15:42 | Voices
Cheng-Hock Toh։ The Unrecognised Central Role of Hematology in Healthcare Design
Cheng-Hock Toh, Chair at National Blood Transfusion Committee,Professor of Medical Haematology at the University of…
Danny Hsu: The Next Frontier in Anticoagulation Beyond DOACs
Mar 2, 2026, 15:58 | Voices
Danny Hsu: The Next Frontier in Anticoagulation Beyond DOACs
Danny Hsu, President of THANZ, shared Journal of Thrombosis and Haemostasis' post on LinkedIn: "Beyond DOACs:…
Heghine Khachatryan: The Future of Anticoagulation Beyond DOACs
Mar 1, 2026, 08:46 | Science
Heghine Khachatryan: The Future of Anticoagulation Beyond DOACs
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology…
Is It Safe to Briefly Stop Anticoagulation After VTE? – RPTH Journal
Feb 24, 2026, 16:01 | Voices
Is It Safe to Briefly Stop Anticoagulation After VTE? – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Lisbeth Eischer et al, adding:…
Tagreed Alkaltham: Tranexamic Acid in PBM
Feb 12, 2026, 16:36 | Voices
Tagreed Alkaltham: Tranexamic Acid in PBM
Tagreed Alkaltham, Transfusion Medicine Lab Supervisor at KSMC, shared a post on LinkedIn: "Tranexamic Acid (TXA)…
Pedro Perez: Post-Thrombectomy DVT Recovery in 2026 - Closing the Loop on Outcomes
Feb 3, 2026, 10:40 | Voices
Pedro Perez: Post-Thrombectomy DVT Recovery in 2026 - Closing the Loop on Outcomes
Pedro Perez, Vascular Consultant – PERT and VTE Program Builder at Argon Medical Devices, Inc.,…
Tareq Abadl: Heparin vs Warfarin
Feb 2, 2026, 17:08 | Voices
Tareq Abadl: Heparin vs Warfarin
Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader Al-Mutawakkil…
Céline Chapelle Shares Clinical Predictors From the API-CAT Trial
Jan 25, 2026, 15:57 | Science
Céline Chapelle Shares Clinical Predictors From the API-CAT Trial
Céline Chapelle, Biostatistician at CHU Saint-Étienne, shared on LinkedIn: "Very happy to share our latest…
Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
Jan 7, 2026, 06:41 | Science
Zain Khalpey on AI Driven Risk Prediction for Optimization of Anticoagulation in LVAD
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared on…
Dr Abdul Mannan: Patient Has CAPS with 7000 Platelets - Do You Anticoagulate?
Jan 6, 2026, 08:49 | Voices
Dr Abdul Mannan: Patient Has CAPS with 7000 Platelets - Do You Anticoagulate?
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on…
Zeeshan Ahmed Khattak: Why Every Pharmacist Should Consider an Anticoagulation Certification
Jan 4, 2026, 20:30 | Voices
Zeeshan Ahmed Khattak: Why Every Pharmacist Should Consider an Anticoagulation Certification
Zeeshan Ahmed Khattak, Pharmacist (IP/Oncology) at Abu Dhabi Stem Cells Center, shared on LinkedIn: ''Why…
Niraj Sharma: Andexxa - Now Voluntarily Withdrawn From the U.S. Market
Dec 31, 2025, 08:31 | Drugs
Niraj Sharma: Andexxa - Now Voluntarily Withdrawn From the U.S. Market
Niraj Sharma, Cardiac Electrophysiologist/Cardiologist at Northside Hospital, shared on LinkedIn: "EP Edge | BREAKING NEWS Just…
Lina Elfaki: Anticoagulation Medications - A Critical Component of Patient Safety
Dec 25, 2025, 03:33 | Drugs
Lina Elfaki: Anticoagulation Medications - A Critical Component of Patient Safety
Lina Elfaki, Senior clinical pharmacist, shared on LinkedIn: "Anticoagulation Medications: A Critical Component of Patient…
Alen Emmanuel Joshy: CT Brain in Intracranial Hemorrhage
Dec 20, 2025, 23:44 | Insight
Alen Emmanuel Joshy: CT Brain in Intracranial Hemorrhage
Alen Emmanuel Joshy, MRI Technician at AKG Memorial Cooperative Hospital, shared on LinkedIn: ”CT Brain…
Abdul Mannan - Breaking in Haem: Andexanet Alfa Withdrawn from US Market
Dec 20, 2025, 11:13 | Drugs
Abdul Mannan - Breaking in Haem: Andexanet Alfa Withdrawn from US Market
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn: "Breaking in…
Niraj Sharma: “Successful Ablation” Does not Equal Stroke Immunity
Dec 20, 2025, 07:02 | Insight
Niraj Sharma: “Successful Ablation” Does not Equal Stroke Immunity
Niraj Sharma, Cardiac Electrophysiologist/Cardiologist at Northside Hospital, shared on LinkedIn: "Can We Really Stop Anticoagulation After…
Gayatri Digambar: Safe Anticoagulation Conversion
Dec 19, 2025, 12:13 | Insight
Gayatri Digambar: Safe Anticoagulation Conversion
Gayatri Digambar, B.Pharm Finalist and Registered Pharmacist, posted on LinkedIn: ''Anticoagulation Conversion Mastering the Transition:…
OCEAN Trial: Rethinking Long-term Anticoagulation after Atrial Fibrillation Ablation
Dec 19, 2025, 12:07 | Science
OCEAN Trial: Rethinking Long-term Anticoagulation after Atrial Fibrillation Ablation
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal,…
Adding Aspirin to Anticoagulation Sounds Smart: The Data Says Otherwise
Dec 19, 2025, 12:05 | Insight
Adding Aspirin to Anticoagulation Sounds Smart: The Data Says Otherwise
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn: ''Adding aspirin…
Joshua Lin and Team: New Evidence on Long-Term Anticoagulation for Unprovoked VTE 
Dec 19, 2025, 11:45 | Science
Joshua Lin and Team: New Evidence on Long-Term Anticoagulation for Unprovoked VTE 
Joshua Lin, Executive Director of Mass General Brigham Center for Integrated Healthcare Data Research, posted…
Mohammad Alashqar in Conversation With Anticoagulation Leader Dr. Gulseth
Dec 19, 2025, 11:40 | Insight
Mohammad Alashqar in Conversation With Anticoagulation Leader Dr. Gulseth
Mohammad Alashqar, Postdoctoral Pharmacotherapy Research Fellow at The Ohio State University College of Pharmacy, posted…
Niraj Sharma: Can We Really Stop Anticoagulation After AF Ablation?
Dec 18, 2025, 12:12 | Insight
Niraj Sharma: Can We Really Stop Anticoagulation After AF Ablation?
Niraj Sharma, Cardiac Electrophysiologist/Cardiologist at Northside Hospital, shared on LinkedIn: ''Can We Really Stop Anticoagulation…
Nicolas Gendron on Sustainability in Anticoagulation and DOACs
Dec 16, 2025, 16:14 | Science
Nicolas Gendron on Sustainability in Anticoagulation and DOACs
Nicolas Gendron, Research Fellow, Hematologist at Boston Children’s Hospital, shared on LinkedIn: ''Anticoagulation and sustainability.…
Mike Sharma: Adding Antiplatelets to Anticoagulation in AF Increases Harm Without Benefit
Dec 16, 2025, 07:13 | Science
Mike Sharma: Adding Antiplatelets to Anticoagulation in AF Increases Harm Without Benefit
Mike Sharma, Senior Scientist at Population Health Research Institute, reposted from JAMA Neurology on LinkedIn:…
How Anticoagulation Differs for Individuals Who Menstruate?
Dec 15, 2025, 09:44 | Science
How Anticoagulation Differs for Individuals Who Menstruate?
Divyaswathi Citla Sridhar, a pediatric hematologist and oncologist at Arkansas Children’s Hospital, posted on LinkedIn:…
Jarosław Kępski: Managing Anticoagulation in Oncology Patients With Thrombocytopenia
Dec 13, 2025, 08:22 | Science
Jarosław Kępski: Managing Anticoagulation in Oncology Patients With Thrombocytopenia
Jarosław Kępski, Cardiologist and member of the ESC Council of Cardio-Oncology (COOL) Committee, reposted from…
Aravind Palraj: Anticoagulation Made Simple - 2025 Update
Dec 13, 2025, 08:13 | Insight
Aravind Palraj: Anticoagulation Made Simple - 2025 Update
Aravind Palraj, Senior Resident in Clinical Immunology and Rheumatology at Madras Medical College, shared a post…
Normal Counts, High Risk: Abdul Mannan Breaks Down JAK2 + Splanchnic Vein Thrombosis
Dec 12, 2025, 22:27 | Science
Normal Counts, High Risk: Abdul Mannan Breaks Down JAK2 + Splanchnic Vein Thrombosis
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn: ''You find…
Aravind Palraj: A Quick Guide to What Clinicians Actually Need
Dec 12, 2025, 09:31 | Insight
Aravind Palraj: A Quick Guide to What Clinicians Actually Need
Aravind Palraj, Senior Resident in Clinical Immunology and Rheumatology at Madras Medical College, shared a post…
Heparin and Warfarin in Pregnancy
Dec 11, 2025, 23:03 | Insight
Heparin and Warfarin in Pregnancy
Samwel Mikaye, CEO of SaMik Medical Center, posted on LinkedIn: ''HEPARIN AND WARFARIN IN PREGNANCY…
ASH25 Highlight - Extended Anticoagulation in VTE: Apixaban vs Rivaroxaban
Dec 8, 2025, 08:27 | Science
ASH25 Highlight - Extended Anticoagulation in VTE: Apixaban vs Rivaroxaban
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared on LinkedIn: ''ASH25 Highlight - Extended…
New ASH25 Insights on Bleeding Risk in Cancer-Associated VTE
Dec 8, 2025, 06:23 | Science
New ASH25 Insights on Bleeding Risk in Cancer-Associated VTE
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared on LinkedIn: ''New Insights on Bleeding…
ASH25 Day 2: Don't Miss The Highlights
Dec 7, 2025, 18:43 | Insight
ASH25 Day 2: Don't Miss The Highlights
The American Society of Hematology Congress 2025 (ASH25) is officially underway in Orlando, Florida, from…
Craig Beavers Challenges the Field: We Need Better Drugs for True Anticoagulation Safety
Dec 7, 2025, 05:19 | Drugs,Science
Craig Beavers Challenges the Field: We Need Better Drugs for True Anticoagulation Safety
Craig Beavers, Vice President of Professional Services at Baptist Health Paducah, posted on LinkedIn: "Provocative…
Craig Beavers: True Anticoagulation Safety Cannot Be Achieved Without Better Anticoagulants
Dec 6, 2025, 06:20 | Science
Craig Beavers: True Anticoagulation Safety Cannot Be Achieved Without Better Anticoagulants
Craig Beavers, Vice President of Professional Services at Baptist Health Paducah, shared on LinkedIn: ”Provocative commentary…
Manoj Khadka: Thrombophilia Testing - When and What to Test?
Dec 5, 2025, 06:11 | Insight
Manoj Khadka: Thrombophilia Testing - When and What to Test?
Manoj Khadka, Resident Doctor at Patan Hospital, posted on LinkedIn: ''When a patient with Deep…
A Dickensian Reality: Warfarin Patients Are Treated Like Orphans - Says Pall Onundarson
Dec 4, 2025, 02:36 | Insight
A Dickensian Reality: Warfarin Patients Are Treated Like Orphans - Says Pall Onundarson
Pall Onundarson, Professor Emeritus at Landspitali University Hospital, posted on LinkedIn: ''I recently read eye-opening…
Interdisciplinary Care for Gynecologic Bleeding on Anticoagulation․ A Recommended Toolkit
Dec 3, 2025, 02:30 | Science
Interdisciplinary Care for Gynecologic Bleeding on Anticoagulation․ A Recommended Toolkit
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of…
Monthly Rapid Recap - Anticoagulation Forum
Dec 3, 2025, 02:27 | Science
Monthly Rapid Recap - Anticoagulation Forum
Anticoagulation Forum shared on LinkedIn: “The latest Rapid Recap is here — your monthly roundup of key…
Frank Verhoeven: Are VTE Events More Likely to Recur in Cases of SpA?
Dec 1, 2025, 15:13 | Insight
Frank Verhoeven: Are VTE Events More Likely to Recur in Cases of SpA?
Frank Verhoeven, Associate Professor in Rheumatology at CHU Besançon, shared on LinkedIn: ''Are venous thromboembolic…
Mohamed Magdy Badr: Post-Thrombotic Limb - The Hidden Burden After DVT
Nov 30, 2025, 14:38 | Insight
Mohamed Magdy Badr: Post-Thrombotic Limb - The Hidden Burden After DVT
Mohamed Magdy Badr, Wound Care Consultant at Armed Force Rehabilitation Center, posted on LinkedIn: ”Post-Thrombotic…
The Diagnostic Pitfall: DOACs and Activated Partial Thromboplastin Time
Nov 28, 2025, 16:44 | Insight
The Diagnostic Pitfall: DOACs and Activated Partial Thromboplastin Time
Mohamed Hanafy Morsy, Associate Professor of Clinical Pathology, Hematopathologist at Makkah Health Cluster, posted on…
Winel Fonbah: Elevating Anticoagulation Literacy
Nov 28, 2025, 16:24 | Insight
Winel Fonbah: Elevating Anticoagulation Literacy
Winel Fonbah, Registered Nurse at Regional hospital limbe, shared a post on LinkedIn: “Elevating Anticoagulation Literacy: A…
Chioma Okpalaora on The Role of Pharmacists in the Periprocedural Management of Anticoagulation
Nov 28, 2025, 10:00 | Insight
Chioma Okpalaora on The Role of Pharmacists in the Periprocedural Management of Anticoagulation
Chioma Okpalaora, Teaching Assistant at Memorial University, Newfoundland and Labrador, shared on LinkedIn: ''This week…
New Podcast With Matthew Watto and Paul Williams: A PCP Guide to Anticoagulation
Nov 27, 2025, 16:37 | Insight,Science
New Podcast With Matthew Watto and Paul Williams: A PCP Guide to Anticoagulation
Nikolay Dimitrov, Professor Structural and Interventional Cardiology at Medical University of Sofia, shared new article on…
Saquib Ahmad: Management of DVT and Follow-Up
Nov 27, 2025, 05:05 | Insight
Saquib Ahmad: Management of DVT and Follow-Up
Saquib Ahmad, General Practitioner at Khyber Medical Centre Madinat Zyed, posted on LinkedIn: ''Management of…
Purpura Fulminans - A Rapidly Progressive Coagulopathic Emergency Across The Lifespan
Nov 27, 2025, 05:03 | Science
Purpura Fulminans - A Rapidly Progressive Coagulopathic Emergency Across The Lifespan
Indunil Karunarathna, Consultant Anaesthetist, Head of the Department, T H Polonnaruwa, Ministry of Health, Sri…
Stefan Gerner on Safety of Tenecteplase Versus Alteplase for IVT
Nov 27, 2025, 03:30 | Science
Stefan Gerner on Safety of Tenecteplase Versus Alteplase for IVT
Stefan Gerner, Senior Physician at Erlangen University Hospital, shared on LinkedIn: ''IVT seems safe in…
Apixaban for Extended Treatment of Provoked VTE: New NEJM Study Challenges Treatment Paradigm
Nov 26, 2025, 04:51 | Science
Apixaban for Extended Treatment of Provoked VTE: New NEJM Study Challenges Treatment Paradigm
Emma P. with Clinical Research Professionals shared a post on LinkedIn: "Apixaban for Extended Treatment…
Ashkan Shoamanesh: Should Intracranial Hemorrhage Survivors with AFib Receive Anticoagulation?
Nov 25, 2025, 09:29 | Science
Ashkan Shoamanesh: Should Intracranial Hemorrhage Survivors with AFib Receive Anticoagulation?
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research…
Dr Zahoor: DVT Can Lead to PE if The Clot Dislodges
Nov 25, 2025, 09:11 | Science
Dr Zahoor: DVT Can Lead to PE if The Clot Dislodges
Dr Zahoor, Senior Medical epidemiologist at National institute of health Islamabad, shared a post on LinkedIn:…
Jack Shuang Hou: Asundexian Hits Phase 3 Stroke Endpoint Without Increasing Bleeding Risk
Nov 25, 2025, 09:00 | Drugs
Jack Shuang Hou: Asundexian Hits Phase 3 Stroke Endpoint Without Increasing Bleeding Risk
Jack Shuang Hou, Scientific Director at Jtests, shared on LinkedIn: ''Bayer Revives FXIa Hopes: Asundexian…
Thomas Reiser: Gynecologic Bleeding and Anticoagulation
Nov 24, 2025, 11:41 | Science
Thomas Reiser: Gynecologic Bleeding and Anticoagulation
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on…
Jon Faldasz: Why Aren’t We Better at Achieving Therapeutic Warfarin Control?
Nov 21, 2025, 08:55 | Voices
Jon Faldasz: Why Aren’t We Better at Achieving Therapeutic Warfarin Control?
Jon Faldasz, Senior Director of Product and Customer Experience at InsightRX, posted on LinkedIn: ”Ok I know…
Mohannad G Abdelgader: Understanding Thrombosis - Silent But Serious
Nov 19, 2025, 15:43 | Insight
Mohannad G Abdelgader: Understanding Thrombosis - Silent But Serious
Mohannad G Abdelgader, Director at Abdulla Fouad Group-Hakeem Laboratories, shared on LinkedIn: ''Understanding Thrombosis: Silent…
Abdulrahman Nasiri: Bone Marrow Biopsy Safety on Anticoagulation
Nov 17, 2025, 05:36 | Blog
Abdulrahman Nasiri: Bone Marrow Biopsy Safety on Anticoagulation
Abdulrahman Nasiri, Hematologist, Assistant Professor at Imam Muhammad ibn Saud Islamic University, posted on LinkedIn:…
Wolfgang Miesbach - ASH 2025: What's Coming in Bleeding and Thrombosis?
Nov 13, 2025, 01:08 | Insight
Wolfgang Miesbach - ASH 2025: What's Coming in Bleeding and Thrombosis?
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''By The Numbers…
Davide Capodanno: Bad News for Left Atrial Appendage Closure Enthusiasts
Nov 10, 2025, 12:37 | Science
Davide Capodanno: Bad News for Left Atrial Appendage Closure Enthusiasts
Davide Capodanno, Professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, shared on LinkedIn: ”Bad…
Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
Nov 10, 2025, 10:14 | Science
Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
Marieke Kruip, Professor haematology and quality of care at Erasmus MC, shared on LinkedIn: ''Our…
Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
Nov 10, 2025, 10:12 | Insight
Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
Mohamed Rawy, Hospital Pharmacist at Specialized Medical Center Hospital, shared on LinkedIn: ''Comprehensive Guide For…
Christian Schulze Shares the CLOSURE AF Insights on Left Atrial Appendage in AFib
Nov 9, 2025, 12:34 | Insight
Christian Schulze Shares the CLOSURE AF Insights on Left Atrial Appendage in AFib
Christian Schulze, Professor of Medicine at Friedrich-Schiller-University Jena, shared on LinkedIn: ''CLOSURE AF presented at…
Mohamed Sherif Salem: Anti-Xa Monitoring Did Not Reduce Bleeding or Thromboembolic Events
Nov 9, 2025, 11:35 | Science
Mohamed Sherif Salem: Anti-Xa Monitoring Did Not Reduce Bleeding or Thromboembolic Events
Mohamed Sherif Salem, Senior Clinical Pharmacist at Andalusia Health Egypt, shared on LinkedIn: ”A 2025…
C. Michael Gibson and Atul Verma on OCEAN Trial: Rivaroxaban VS Aspirin in AF
Nov 8, 2025, 11:18 | Insight
C. Michael Gibson and Atul Verma on OCEAN Trial: Rivaroxaban VS Aspirin in AF
C Michael Gibson, President and CEO at Baim Institute for Clinical Research, shared on LinkedIn:…
Babak Alex Vakili: Net Clinical Benefit Favors OAC Alone, According to the AQUATIC Trial
Nov 7, 2025, 01:34 | Insight
Babak Alex Vakili: Net Clinical Benefit Favors OAC Alone, According to the AQUATIC Trial
Babak Alex Vakili, President and CEO at Heart Vein and Vascular Clinic, shared on LinkedIn:…
Study Finds NOACs as Safe and Effective as Warfarin in CVST
Nov 6, 2025, 07:08 | Science
Study Finds NOACs as Safe and Effective as Warfarin in CVST
SCCM Neuroscience Section posted on X: ''Use of new oral anticoagulants (NOACs) in cerebral venous…
Sebastian Szmit: Advances in Managing Cancer-Associated Thromboembolism
Nov 6, 2025, 05:02 | Science
Sebastian Szmit: Advances in Managing Cancer-Associated Thromboembolism
OncoDaily shared on LinkedIn: ”Dr. Sebastian Szmit Highlights Advances in Managing Cancer-Associated Thromboembolism at GCOS 2025…
David V - Anticoagulant Reversal: Critical Insights for Clinicians
Nov 5, 2025, 05:20 | Insight
David V - Anticoagulant Reversal: Critical Insights for Clinicians
David V, Student at Vinayaka Mission's Research Foundation - University, posted on LinkedIn: ''Anticoagulant Reversal:…
Penumbra Announces Secondary Results of the Ground-Breaking STORM - PE RCT
Nov 5, 2025, 05:14 | Insight
Penumbra Announces Secondary Results of the Ground-Breaking STORM - PE RCT
Romain Buisson, Country Manager (TH-HK cluster) at Penumbra, Inc., shared a post by Penumbra, Inc.…
Abdul Mannan on Finding the Right Balance - The Blood Thinner Dilemma
Nov 1, 2025, 02:14 | Insight
Abdul Mannan on Finding the Right Balance - The Blood Thinner Dilemma
  Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn: ''Stopping…
Rachel Rosovsky Presents STORM-PE RCT Results at VIVA 2025
Oct 31, 2025, 02:06 | Voices
Rachel Rosovsky Presents STORM-PE RCT Results at VIVA 2025
  Rachel Rosovsky, Hematologist at Massachusetts General Hospital, posted on LinkedIn: ''The first-and only-RCT demonstrating…
Thomas Reiser and ISTH Guidance and Guidelines Committee Invite a Public Review
Oct 29, 2025, 02:01 | Insight
Thomas Reiser and ISTH Guidance and Guidelines Committee Invite a Public Review
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on…
Tahereh Yavari: Antiphospholipid Syndrome — From Thrombosis to Thrombo-inflammation
Oct 28, 2025, 06:50 | Insight
Tahereh Yavari: Antiphospholipid Syndrome — From Thrombosis to Thrombo-inflammation
Tahereh Yavari, Rheumatology fellowship at Tehran University of Medical Sciences (TUMS), shared a post on LinkedIn: “Antiphospholipid…
Marc Carrier: Are You the One Everyone Calls When Anticoagulation Gets Complicated?
Oct 24, 2025, 10:06 | Organizations
Marc Carrier: Are You the One Everyone Calls When Anticoagulation Gets Complicated?
Marc Carrier, Professor at Ottawa Hospital Research Institute, has posted on LinkedIn: "Are you the…
Jurjen Krommenhoek and Colleagues Propose a Clinical Care Pathway for Major Bleeding Survivors
Oct 22, 2025, 09:37 | Science
Jurjen Krommenhoek and Colleagues Propose a Clinical Care Pathway for Major Bleeding Survivors
RPTH Journal shared on LinkedIn: ''Major bleeding frequently complicates anticoagulant therapy. In this narrative review,…
Laurent Bertoletti Highlights Evolving Role of Anticoagulation in Pulmonary Hypertension Treatment
Oct 20, 2025, 12:25 | Voices
Laurent Bertoletti Highlights Evolving Role of Anticoagulation in Pulmonary Hypertension Treatment
Laurent Bertoletti, University Professor and Hospital Practitioner at Jean Monnet University, Saint-Etienne, shared on LinkedIn:…
Sebastian Szmit: Important Review Published Today By My Research Group
Oct 20, 2025, 05:31 | Science
Sebastian Szmit: Important Review Published Today By My Research Group
Sebastian Szmit, Head of Department of Cardio-Oncology, Centrum Medycznego Kształcenia Podyplomowego, shared on LinkedIn: ''Important…
Nazim Arain Shares The New Standard: Anticoagulation in Cirrhosis
Oct 19, 2025, 04:59 | Science
Nazim Arain Shares The New Standard: Anticoagulation in Cirrhosis
Nazim Arain, Consultant Internal Medicine and Gastroenterologist at Almana Group of Hospitals, shared on LinkedIn:…
Tahereh Yavari — Anticoagulation in Behçet’s Syndrome: Revisiting an Ongoing Debate
Oct 18, 2025, 05:20 | Science
Tahereh Yavari — Anticoagulation in Behçet’s Syndrome: Revisiting an Ongoing Debate
Tahereh Yavari, Rheumatology fellowship at Tehran University of Medical Sciences (TUMS), shared a post on…
Multiple Retinal Artery Occlusions on Anticoagulation - What’s Next?
Oct 17, 2025, 06:40 | Science
Multiple Retinal Artery Occlusions on Anticoagulation - What’s Next?
  American Society of Retina Specialists (ASRS) posted on LinkedIn: ''How would you manage a…
Jennifer Glen: Play Free Digital Anticoagulation Assessments
Oct 17, 2025, 06:39 | Insight
Jennifer Glen: Play Free Digital Anticoagulation Assessments
  Jennifer Glen, CMO of EVAL Health, shared a post by World Thrombosis Day on…
Not All Thrombotic Microangiopathies Behave the Same - Published in RPTH
Oct 17, 2025, 06:38 | Science
Not All Thrombotic Microangiopathies Behave the Same - Published in RPTH
  RPTH Journal posted on LinkedIn: ''Not all thrombotic microangiopathies (TMAs) behave the same, and…
Lara Roberts Published "Anticoagulation in Cirrhosis: The New Standard"
Oct 16, 2025, 06:13 | Science
Lara Roberts Published "Anticoagulation in Cirrhosis: The New Standard"
Nazim Arain, Consultant Internal Medicine & Gastroenterologist at Almana Group of Hospitals, shared a post…
Abedalrahman Maen Addassi: Edoxaban’s Journey Shows How Targeted Pharmacology and Real-World Data Converge
Oct 16, 2025, 05:58 | Drugs
Abedalrahman Maen Addassi: Edoxaban’s Journey Shows How Targeted Pharmacology and Real-World Data Converge
Abedalrahman Maen Addassi, Pharmacist, shared a post on LinkedIn: ”Innovation in Anticoagulation: Edoxaban by Daiichi…
Evaluating Drug–Drug Interactions in Cancer Patients Receiving Anticoagulants and Antineoplastics
Oct 12, 2025, 01:32 | Science
Evaluating Drug–Drug Interactions in Cancer Patients Receiving Anticoagulants and Antineoplastics
Despoina Pantazi, Teaching Staff at the Department of Chemistry, University of Ioannina, shared a post…
RPTH Journal: Does Fasting Affect Anticoagulant Therapy? - The Effects Of Fasting During Ramadan
Oct 11, 2025, 08:33 | Insight
RPTH Journal: Does Fasting Affect Anticoagulant Therapy? - The Effects Of Fasting During Ramadan
  RPTH Journal posted on LinkedIn: ''Does fasting affect anticoagulant therapy? This study investigated the…
All: 362 Posts: 201 - 300
NewsFeed